PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 24, 2016Journal of Medicinal Chemistry120 citationsOpen Access

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

CCChristopher R. CoxonEAElizabeth AnscombeSHSuzannah J. Harnor

Key Points

Key points are not available for this paper at this time.

Abstract

86 μM). This compound is therefore a useful tool for studies of cell cycle regulation. Crystal structures of inhibitor-kinase complexes showed that the inhibitor stabilizes a glycine-rich loop conformation that shapes the ATP ribose binding pocket and that is preferred in CDK2 but has not been observed in CDK1. This aspect of the active site may be exploited for the design of inhibitors that distinguish between CDK1 and CDK2.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Coxon et al. (2016) studied this question.

synapsesocial.com/papers/69fd7c3c37bfdcfbd750b042https://doi.org/10.1021/acs.jmedchem.6b01254
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preparation of 2,5-diamino-4,6-dichloropyrimidine1975 · 33 citations
  2. 2Synthesis of Potential Anticancer Agents. XX. 2-Fluoropurines21960 · 89 citations
  3. 3The synthesis of certain 5,7‐Dihydroxyimidazo[1,2‐a| pyrimidines1973 · 14 citations
  4. 4Cyclin-dependent kinase inhibitors move into Phase III2012 · 71 citations
  5. 5Synthesis and antimicrobial activity of certain imidazo[1,2-a]pyrimidines1975 · 65 citations